Literature DB >> 2259230

Elevated argininosuccinate synthetase activity in adult T leukemia cell lines.

K Sugimura1, T Kimura, H Arakawa, T Ohno, Y Wada, Y Kimura, T Saheki, I Azuma.   

Abstract

Argininosuccinate synthetase (ASS) is a ATP-dependent and rate-limiting enzyme of the urea cycle which catalyzes L-citrulline to L-arginine in combination with argininosuccinate lyase (ASL). We demonstrate here that (a) human normal T and B lymphocytes did not express ASS activity, (b) however, three adult T leukemia (ATL) cell lines tested here exhibited significant elevation of ASS activity, and (c) ASL activity remained relatively constant in normal lymphocytes and various leukemia cell lines. These results suggest that the ASS expression of peripheral blood lymphocytes is of value as a diagnostic marker of leukemia including ATL. The implication of these results is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2259230     DOI: 10.1016/0145-2126(90)90184-b

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  11 in total

Review 1.  Arginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma.

Authors:  N Savaraj; M You; C Wu; M Wangpaichitr; M T Kuo; L G Feun
Journal:  Curr Mol Med       Date:  2010-06       Impact factor: 2.222

2.  Impaired T cell function in argininosuccinate synthetase deficiency.

Authors:  Tatyana N Tarasenko; Julio Gomez-Rodriguez; Peter J McGuire
Journal:  J Leukoc Biol       Date:  2014-12-09       Impact factor: 4.962

3.  Polymorphism in genes for the enzyme arginine deiminase among Mycoplasma species.

Authors:  K Sugimura; T Ohno; I Azuma; K Yamamoto
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

4.  Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer.

Authors:  Jung-hyun Rho; Shuzhen Qin; Julia Y Wang; Michael H A Roehrl
Journal:  J Proteome Res       Date:  2008-06-13       Impact factor: 4.466

5.  Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity.

Authors:  Livingstone Fultang; Sarah Booth; Orli Yogev; Barbara Martins da Costa; Vanessa Tubb; Silvia Panetti; Victoria Stavrou; Ugo Scarpa; Andris Jankevics; Gavin Lloyd; Andrew Southam; Steven P Lee; Warwick B Dunn; Louis Chesler; Francis Mussai; Carmela De Santo
Journal:  Blood       Date:  2020-09-03       Impact factor: 22.113

6.  Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation.

Authors:  Nicholas T Crump; Andreas V Hadjinicolaou; Meng Xia; John Walsby-Tickle; Uzi Gileadi; Ji-Li Chen; Mashiko Setshedi; Lars R Olsen; I-Jun Lau; Laura Godfrey; Lynn Quek; Zhanru Yu; Erica Ballabio; Mike B Barnkob; Giorgio Napolitani; Mariolina Salio; Hashem Koohy; Benedikt M Kessler; Stephen Taylor; Paresh Vyas; James S O McCullagh; Thomas A Milne; Vincenzo Cerundolo
Journal:  Cell Rep       Date:  2021-05-11       Impact factor: 9.423

7.  Reconstitution of T Cell Proliferation under Arginine Limitation: Activated Human T Cells Take Up Citrulline via L-Type Amino Acid Transporter 1 and Use It to Regenerate Arginine after Induction of Argininosuccinate Synthase Expression.

Authors:  Anke Werner; Miriam Koschke; Nadine Leuchtner; Claudia Luckner-Minden; Alice Habermeier; Johanna Rupp; Christin Heinrich; Roland Conradi; Ellen I Closs; Markus Munder
Journal:  Front Immunol       Date:  2017-07-24       Impact factor: 7.561

8.  l-Citrulline Metabolism in Mice Augments CD4+ T Cell Proliferation and Cytokine Production In Vitro, and Accumulation in the Mycobacteria-Infected Lung.

Authors:  Shannon M Lange; Melanie C McKell; Stephanie M Schmidt; Austin P Hossfeld; Vandana Chaturvedi; Jeremy M Kinder; Jaclyn W McAlees; Ian P Lewkowich; Sing Sing Way; Joanne Turner; Joseph E Qualls
Journal:  Front Immunol       Date:  2017-11-16       Impact factor: 7.561

9.  Arginine deprivation, growth inhibition and tumour cell death: 3. Deficient utilisation of citrulline by malignant cells.

Authors:  D N Wheatley; E Campbell
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640

Review 10.  The Role of Amino Acids in the Crosstalk Between Mesenchymal Stromal Cells and Neoplastic Cells in the Hematopoietic Niche.

Authors:  Martina Chiu; Giuseppe Taurino; Massimiliano G Bianchi; Ovidio Bussolati
Journal:  Front Cell Dev Biol       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.